Participants:18–64 years · 65+ years
Substances:2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE

Contact Research Centre

Soft tissue necrosis

Recruiting

Registered drugNo placebo

Evaluating Hyperbaric Oxygen Treatment in Addition to Standard Care for Patients with Necrotizing Soft-Tissue Infection

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Oxygen

Contact Research Centre

B-cell small lymphocytic lymphoma refractory+1

Recruiting

Registered drugNo placebo

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Obinutuzumab

Contact Research Centre

Ovarian cancer

Recruiting

Registered drugNo placebo

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Acromegaly

Recruiting

Registered drug

Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Neoplasm

Recruiting

Registered drugNo placebo

Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Hypochondroplasia

Recruiting

Registered drug

Study on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature

Registered drug

Sweden

Participants:0–17 years
Substances:Infigratinib

Contact Research Centre

Phenylketonuria

Recruiting

Registered drugNo placebo

Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

Registered drugNo placebo

Sweden

Participants:0–17 years
Substances:Sepiapterin

Contact Research Centre

Endometrial cancer

Recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Find therapies in clinical trials near you – page 6

377 trials match your criteria

Triple negative breast cancer

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Cardiomyopathy

Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

Neoplasm malignant

Study of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment

Soft tissue necrosis

Evaluating Hyperbaric Oxygen Treatment in Addition to Standard Care for Patients with Necrotizing Soft-Tissue Infection

B-cell small lymphocytic lymphoma refractory+1

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Ovarian cancer

Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

Acromegaly

Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

Neoplasm

Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

Hypochondroplasia

Study on the Effectiveness and Safety of Infigratinib for Children with Hypochondroplasia and Short Stature

Phenylketonuria

Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

Endometrial cancer

Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

Prostate cancer

Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.